These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11156404)

  • 1. Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model.
    Zuckier LS; Berkowitz EZ; Sattenberg RJ; Zhao QH; Deng HF; Scharff MD
    Cancer Res; 2000 Dec; 60(24):7008-13. PubMed ID: 11156404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
    Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays.
    Kaufman EN; Jain RK
    Cancer Res; 1992 Aug; 52(15):4157-67. PubMed ID: 1638531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.
    Le Doussal JM; Barbet J; Delaage M
    Int J Cancer Suppl; 1992; 7():58-62. PubMed ID: 1428406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
    Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable region differences affect antibody binding to immobilized but not soluble antigen.
    Horgan C; Brown K; Pincus SH
    Hum Antibodies Hybridomas; 1992 Jul; 3(3):153-7. PubMed ID: 1391665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on antigen binding by intact and hinge-deleted chimeric antibodies.
    Horgan C; Brown K; Pincus SH
    J Immunol; 1993 Jun; 150(12):5400-7. PubMed ID: 7685795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate.
    Le Doussal JM; Martin M; Gautherot E; Delaage M; Barbet J
    J Nucl Med; 1989 Aug; 30(8):1358-66. PubMed ID: 2787847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting behavior of rat monoclonal IgG antibodies in vivo: role of antibody isotype, specificity and the target cell antigen density.
    Yousaf N; Howard JC; Williams BD
    Eur J Immunol; 1991 Apr; 21(4):943-50. PubMed ID: 2019290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
    Adams GP; Schier R; McCall AM; Simmons HH; Horak EM; Alpaugh RK; Marks JD; Weiner LM
    Cancer Res; 2001 Jun; 61(12):4750-5. PubMed ID: 11406547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced binding to antigen of monoclonal antibodies modified with a crosslinker.
    Ueno H; Masuko T; Wang J; Hashimoto Y
    Biochem Biophys Res Commun; 1993 Mar; 191(2):701-8. PubMed ID: 8096384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency.
    Scallon B; Cai A; Radewonuk J; Naso M
    Mol Immunol; 2004 May; 41(1):73-80. PubMed ID: 15140577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.
    Juweid M; Neumann R; Paik C; Perez-Bacete MJ; Sato J; van Osdol W; Weinstein JN
    Cancer Res; 1992 Oct; 52(19):5144-53. PubMed ID: 1327501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.
    Graff CP; Wittrup KD
    Cancer Res; 2003 Mar; 63(6):1288-96. PubMed ID: 12649189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitizer conjugation to the carcinoma 19-9 monoclonal antibody.
    Borlinghaus KP; Fitzpatrick DA; Heindel ND; Mattis JA; Mease BA; Schray KJ; Shealy DJ; Walton HL; Woo DV
    Cancer Res; 1987 Aug; 47(15):4071-5. PubMed ID: 3496956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.